About this trial
This study aims to determine whether isobaric ropivacaine is more suitable than isobaric bupivacaine for spinal anesthesia in outpatient total hip arthroplasty (THA). The study will evaluate whether ropivacaine allows faster recovery of sensory and motor function while still providing adequate surgical anesthesia and postoperative pain control. Additional aims are to assess the effects of the anesthetic technique on same-day discharge rates, postoperative recovery, urinary retention, opioid consumption, and patient satisfaction after outpatient THA.
Eligibility criteria
Qualifiers
18 - 80 years of age
Scheduled for a primary elective total hip arthroplasty
Patient must be a candidate for same day discharge
Informed consent understood and signed
Disqualifiers
Scheduled bilateral THA
Contraindication to or failed spinal anesthesia
Allergy or contraindication to NSAIDs (e.g. chronic kidney disease)
Diabetes requiring insulin medication
Trial design
Treatments tested in this trial
- Spinal Anesthesia with Ropivacaine 15 mg (5 mg/ml)
- Spinal Anesthesia with Bupivacaine 11 mg (5 mg/ml)
Treatment groups
Locations
Sponsors and collaborators
University of Turku
Lead sponsor
Turku University Hospital
Collaborator